WuXi AppTec Honored for Sustainable Practices by Dow Jones Indices for Fourth Straight Year

WuXi AppTec's Sustainability Commitment Recognized

WuXi AppTec, a leading player in the global pharmaceutical and life science sectors, has once again been recognized for its unwavering commitment to sustainability. The company has been featured in the esteemed Dow Jones Sustainability Indices (DJSI) for the fourth consecutive year, a testament to its dedicated endeavors to integrate responsible practices throughout its operations.

This prestigious acknowledgment includes WuXi AppTec in both the DJSI World and the DJSI Emerging Markets indices for 2024. These indices serve as benchmarks for evaluating the sustainability performance of companies worldwide, focusing on long-term economic, environmental, and social factors. Inclusion in these indices is not only an honor but an important signal to investors who prioritize sustainability in their portfolios.

The DJSI World highlights the top 10% of the largest 2,500 companies in the S&P Global BMI, while the DJSI Emerging Markets identifies the leading 10% of the biggest 800 firms across 20 emerging markets. WuXi AppTec’s inclusion underscores its position among the sustainability front-runners in the life sciences industry.

In the recent SP Global Corporate Sustainability Assessment (CSA), WuXi AppTec achieved the first position in the Life Sciences Tools & Services sector for 2024, distinguishing itself as a leader among its peers. Globally, it stands out as one of only four companies in its sector to be recognized in the DJSI World this year, and it is notably the sole company from its sector acknowledged in the DJSI Emerging Markets.

Edward Hu, Vice Chairman of WuXi AppTec and Chairman of its ESG Committee, expressed pride in the recognition, stating, "We are honored that WuXi AppTec has been recognized by DJSI for its commitment to advancing sustainability and has once again been included in both the DJSI World and the DJSI Emerging Markets. We will continue to emphasize our ESG commitment while supporting our customers to develop and deliver innovative new therapies to patients worldwide."

WuXi AppTec is deeply invested in upholding high standards in Environmental, Social, and Governance (ESG) criteria. It takes an integrated approach across all facets of global operations to incorporate ESG priorities, which reflects its dedication to environmental stewardship.

In 2024, the company not only ranked first in the Global Life Sciences Tools & Services Industry according to SP Global's CSA, but it also received an 'AA' ESG rating from MSCI for the fourth year in a row. Further validating its sustainability efforts, WuXi AppTec earned a gold medal in the EcoVadis sustainability ratings and was featured in the SP Global Sustainability Yearbook and the FTSE4Good Index Series in both 2023 and 2024.

WuXi's commitment to sustainability is recognized far beyond traditional business metrics. It has received accolades from major global ESG rating agencies, including CDP and ISS, demonstrating wide acknowledgment of its outstanding ESG performance.

Moreover, WuXi AppTec participates vigorously in global sustainability initiatives. It joined the United Nations Global Compact (UNGC) in 2024 to back its ten foundational sustainability principles. In the previous year, the company also became a participant in the Science Based Targets initiative (SBTi) to commit to reducing carbon emissions effectively.

In summary, WuXi AppTec's consistent recognition by the DJSI highlights its crucial role as a catalyst for innovation within the life sciences industry. With a broad portfolio of R&D and manufacturing services, the company plays a significant role in advancing healthcare solutions globally. Through its commitment to sustainability, WuXi AppTec aims to inspire other companies in the sector to follow suit, realizing a vision where every disease can be treated and every drug developed can enhance health outcomes worldwide.

About WuXi AppTec

WuXi AppTec operates on a global scale with a presence in Asia, Europe, and North America. The company offers a wide array of R&D and manufacturing services, empowering the pharmaceutical and life sciences industries to make significant discoveries and breakthroughs. By employing unique business models and integrated services, WuXi AppTec aims to enhance the productivity of healthcare products while providing cost-effective and efficient solutions. The company’s dedication to improving health globally resonates in its approach and community involvement.